Clovis Oncology ups IPO to raise up to $160M
This article was originally published in Scrip
Executive Summary
Clovis Oncology, a startup biopharmaceutical firm in Boulder, Colorado, has amended a filing for an initial public offering and states in a prospectus with the US Securities and Exchange Commission that it has priced its shares at between $13 and $15 per share.